Lipid Emulsion Pretreatment Decreased the Maximum Total and Free Plasma Concentration of Levobupivacaine for Femoral and Sciatic Nerve Block in Below-Knee Fracture Surgery. Issue 8 (1st November 2018)
- Record Type:
- Journal Article
- Title:
- Lipid Emulsion Pretreatment Decreased the Maximum Total and Free Plasma Concentration of Levobupivacaine for Femoral and Sciatic Nerve Block in Below-Knee Fracture Surgery. Issue 8 (1st November 2018)
- Main Title:
- Lipid Emulsion Pretreatment Decreased the Maximum Total and Free Plasma Concentration of Levobupivacaine for Femoral and Sciatic Nerve Block in Below-Knee Fracture Surgery
- Authors:
- Chen, Ying
Zhang, Jian
Chen, Zhe
Wang, Quanguang
Li, Bing
Lai, Rujing
Xu, Xuzhong
Cao, Zhifang
Yu, Lizhen - Abstract:
- Abstract : Background and Objectives: Although intravenous lipid emulsion has been proved a powerful antidote for local anesthetic toxicity, there are few pharmacokinetic data on using lipid infusion as a pretreatment for other clinical applications. We assessed the influence of lipid pretreatment on the pharmacodynamics and pharmacokinetics of levobupivacaine. Methods: Altogether, 12 patients undergoing below-knee surgery for a fracture were randomly assigned to 2 groups (6 patients per group): pretreatment with 1.5 mL/kg lipid infusion (lipid group) or saline infusion (control subjects) followed by complete femoral and sciatic nerve block with 0.375% levobupivacaine (2.5 mg/kg). Total and free (non–protein bound) plasma levobupivacaine concentrations and triglycerides in the lipid group were determined. Results: Results were given as means ± SD. Total and free maximum plasma levobupivacaine concentrations were lower in the lipid group than in control subjects (865 ± 98 vs 1145 ± 177 μg/L and 56.8 ± 7.5 vs 78.2 ± 13.7 μg/L, respectively; P < 0.01). Apparent volume of distribution and clearance were higher in the lipid group than in control subjects (211 ± 35 vs 170 ± 21 L and 35.1 ± 8.0 vs 25.8 ± 2.6 L/h, respectively; P < 0.05). Triglyceride level was significantly higher at the end of lipid infusion than baseline values (7.59 ± 1.32 vs 1.34 ± 0.39 mmol/L; P < 0.01). Conclusions: Lipid pretreatment increased the apparent volume of distribution and clearance and decreasedAbstract : Background and Objectives: Although intravenous lipid emulsion has been proved a powerful antidote for local anesthetic toxicity, there are few pharmacokinetic data on using lipid infusion as a pretreatment for other clinical applications. We assessed the influence of lipid pretreatment on the pharmacodynamics and pharmacokinetics of levobupivacaine. Methods: Altogether, 12 patients undergoing below-knee surgery for a fracture were randomly assigned to 2 groups (6 patients per group): pretreatment with 1.5 mL/kg lipid infusion (lipid group) or saline infusion (control subjects) followed by complete femoral and sciatic nerve block with 0.375% levobupivacaine (2.5 mg/kg). Total and free (non–protein bound) plasma levobupivacaine concentrations and triglycerides in the lipid group were determined. Results: Results were given as means ± SD. Total and free maximum plasma levobupivacaine concentrations were lower in the lipid group than in control subjects (865 ± 98 vs 1145 ± 177 μg/L and 56.8 ± 7.5 vs 78.2 ± 13.7 μg/L, respectively; P < 0.01). Apparent volume of distribution and clearance were higher in the lipid group than in control subjects (211 ± 35 vs 170 ± 21 L and 35.1 ± 8.0 vs 25.8 ± 2.6 L/h, respectively; P < 0.05). Triglyceride level was significantly higher at the end of lipid infusion than baseline values (7.59 ± 1.32 vs 1.34 ± 0.39 mmol/L; P < 0.01). Conclusions: Lipid pretreatment increased the apparent volume of distribution and clearance and decreased the maximum total and free levobupivacaine concentrations, thus offering a reasonable explanation for the effects of lipids on local anesthesia–related toxicity in humans. Rapid lipid infusion induced hypertriglyceridemia without other apparent risks in this study. Clinical Trial Registration: This study was registered at the Chinese Clinical Trial Registry, identifier ChiCTR-TRC-14005203. … (more)
- Is Part Of:
- Regional anesthesia and pain medicine. Volume 43:Issue 8(2018)
- Journal:
- Regional anesthesia and pain medicine
- Issue:
- Volume 43:Issue 8(2018)
- Issue Display:
- Volume 43, Issue 8 (2018)
- Year:
- 2018
- Volume:
- 43
- Issue:
- 8
- Issue Sort Value:
- 2018-0043-0008-0000
- Page Start:
- 838
- Page End:
- 843
- Publication Date:
- 2018-11-01
- Subjects:
- Conduction anesthesia -- Periodicals
Pain medicine -- Periodicals
617.964 - Journal URLs:
- http://www.rapm.org/ ↗
https://journals.lww.com/rapm/pages/default.aspx ↗
http://www.sciencedirect.com/science/journal/10987339 ↗
https://rapm.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/AAP.0000000000000834 ↗
- Languages:
- English
- ISSNs:
- 1098-7339
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7336.572210
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18481.xml